- Home
- SGRP vs PRLD Comparison
SGRP vs PRLD Comparison
Compare SGRP & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- PRLD
- Stock Information
- Founded
- SGRP 1967
- PRLD 2016
- Country
- SGRP United States
- PRLD United States
- Employees
- SGRP N/A
- PRLD N/A
- Industry
- SGRP Business Services
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- SGRP Consumer Discretionary
- PRLD Health Care
- Exchange
- SGRP Nasdaq
- PRLD Nasdaq
- Market Cap
- SGRP 52.3M
- PRLD 53.4M
- IPO Year
- SGRP 1996
- PRLD 2020
- Fundamental
- Price
- SGRP $1.90
- PRLD $0.98
- Analyst Decision
- SGRP
- PRLD Buy
- Analyst Count
- SGRP 0
- PRLD 3
- Target Price
- SGRP N/A
- PRLD $4.33
- AVG Volume (30 Days)
- SGRP 164.6K
- PRLD 450.1K
- Earning Date
- SGRP 12-24-2024
- PRLD 11-06-2024
- Dividend Yield
- SGRP N/A
- PRLD N/A
- EPS Growth
- SGRP N/A
- PRLD N/A
- EPS
- SGRP 0.50
- PRLD N/A
- Revenue
- SGRP $228,869,000.00
- PRLD $3,000,000.00
- Revenue This Year
- SGRP N/A
- PRLD N/A
- Revenue Next Year
- SGRP N/A
- PRLD N/A
- P/E Ratio
- SGRP $3.81
- PRLD N/A
- Revenue Growth
- SGRP N/A
- PRLD N/A
- 52 Week Low
- SGRP $0.92
- PRLD $0.80
- 52 Week High
- SGRP $3.12
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- SGRP 35.42
- PRLD 34.45
- Support Level
- SGRP $1.70
- PRLD $0.80
- Resistance Level
- SGRP $2.05
- PRLD $0.95
- Average True Range (ATR)
- SGRP 0.10
- PRLD 0.09
- MACD
- SGRP -0.02
- PRLD 0.02
- Stochastic Oscillator
- SGRP 34.48
- PRLD 22.04
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.